BAJAJ BROKING

Notification
No new Notification messages
Suraksha Diagnostic IPO is Open!
Apply for the Suraksha Diagnostic IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
entero healthcare solu l stock

ENTERO HEALTHCARE SOLU L Share Price

1349.8 -3.00 (-0.22%)
Dec 02 2024 03:29 PM Retail NSE: ENTERO

ENTERO HEALTHCARE SOLU L Share Price Update

As of the latest trading session, ENTERO HEALTHCARE SOLU L share price is currently at 1349.8, which is down by -3.00 from its previous closing. Today, the stock has fluctuated between 1334.20 and 1365.00. Over the past year, ENTERO HEALTHCARE SOLU L has achieved a return of 17.68 %. In the last month alone, the return has been -0.19 %. Read More...

ENTERO HEALTHCARE SOLU L Performance

Day Range

Low1334.20 High1365.00
1354.25

52 Week Range

Low 970.00 High 1584.25
1354.25

ENTERO HEALTHCARE SOLU L Share Price

22717

544122

ENTERO

img img img img
No Data Available

Open Price

1350.00

Prev. Close

1352.80

Volume (Shares)

32438.00

Total traded value

439.29

Upper Circuit

1623.35

Lower Circuit

1082.25

Note: The current prices & values are delayed, Login to your account for live updates.

ENTERO HEALTHCARE SOLU L Fundamentals


(Standalone)

Market Cap (Cr) 5870.78
PE Ratio (TTM) 79.09
Book Value / Share 382.51
Beta 0.35
ROE 4.83%
EPS (TTM) 17.11
Dividend Yield 0.00%
Net Profit Qtr (Cr) 15.33

ENTERO HEALTHCARE SOLU L Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars SEP 2024 (Values in Cr)
Revenue 112.83
Operating Expense 121.43
Net Profit 15.33
Net Profit Margin (%) 13.58
Earnings Per Share (EPS) 3.52
EBITDA 22.74
Effective Tax Rate (%) 24.18
Particulars JUN 2024 (Values in Cr)
Revenue 122.38
Operating Expense 126.81
Net Profit 20.88
Net Profit Margin (%) 17.06
Earnings Per Share (EPS) 4.80
EBITDA 30.32
Effective Tax Rate (%) 24.76
Particulars MAR 2024 (Values in Cr)
Revenue 106.56
Operating Expense 123.09
Net Profit 37.28
Net Profit Margin (%) 34.98
Earnings Per Share (EPS) 10.19
EBITDA 33.21
Effective Tax Rate (%) -44.10
Particulars DEC 2023 (Values in Cr)
Revenue 76.59
Operating Expense 92.13
Net Profit 0.95
Net Profit Margin (%) 1.24
Earnings Per Share (EPS) 0.58
EBITDA 7.75
Effective Tax Rate (%) -35.71
Particulars SEP 2023 (Values in Cr)
Revenue 73.81
Operating Expense 92.62
Net Profit -2.14
Net Profit Margin (%) -2.89
Earnings Per Share (EPS) -1.33
EBITDA 7.32
Effective Tax Rate (%) 6.11
Particulars MAR 2024 (Values in Cr)
Revenue 318.16
Operating Expense 383.71
Net Profit 38.44
Net Profit Margin (%) 12.08
Earnings Per Share (EPS) 10.63
EBITDA 55.44
Effective Tax Rate (%) -57.77
Particulars MAR 2023 (Values in Cr)
Revenue 177.69
Operating Expense 242.71
Net Profit -12.46
Net Profit Margin (%) -7.01
Earnings Per Share (EPS) -30.28
EBITDA 8.64
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 137.29
Operating Expense 205.01
Net Profit -40.85
Net Profit Margin (%) -29.75
Earnings Per Share (EPS) -0.72
EBITDA -26.85
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 104.87
Operating Expense 146.45
Net Profit -18.15
Net Profit Margin (%) -17.30
Earnings Per Share (EPS) -1811.60
EBITDA -8.54
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 376.21
ROE % 4.96
ROCE % 6.63
Total Debt to Total Equity 0.35
EBITDA Margin 3.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share -166.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.69
EBITDA Margin 2.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share -150.52
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.53
EBITDA Margin 1.15
Particulars MAR 2021 (Values in Cr)
Book Value / Share -3174.60
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.42
EBITDA Margin 1.43
Particulars MAR 2024 (Values in Cr)
Book Value / Share 373.53
ROE % 4.83
ROCE % 3.91
Total Debt to Total Equity 0.06
EBITDA Margin 17.42
Particulars MAR 2023 (Values in Cr)
Book Value / Share -194.27
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.15
EBITDA Margin 4.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share -176.06
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin -19.55
Particulars MAR 2021 (Values in Cr)
Book Value / Share -3067.50
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.05
EBITDA Margin -8.15
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 893.18
Total Assets 2344.97
Total Liabilities 2344.97
Total Equity 1641.38
Share Outstanding 43493767
Price to Book Ratio 2.64
Return on Assets (%) 1.66
Return on Capital (%) 2.04
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 106.84
Total Assets 1308.72
Total Liabilities 1308.72
Total Equity 597.66
Share Outstanding 4111527
Price to Book Ratio 0.00
Return on Assets (%) -0.88
Return on Capital (%) -1.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 105.39
Total Assets 1125.98
Total Liabilities 1125.98
Total Equity 563.21
Share Outstanding 3850000
Price to Book Ratio 0.00
Return on Assets (%) -2.65
Return on Capital (%) -3.53
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 82.82
Total Assets 833.78
Total Liabilities 833.78
Total Equity 487.06
Share Outstanding 100200
Price to Book Ratio 0.00
Return on Assets (%) -1.86
Return on Capital (%) -2.47
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 792.35
Total Assets 1768.58
Total Liabilities 1768.58
Total Equity 1626.41
Share Outstanding 43493767
Price to Book Ratio 2.64
Return on Assets (%) 2.17
Return on Capital (%) 2.36
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 77.18
Total Assets 763.56
Total Liabilities 763.56
Total Equity 583.73
Share Outstanding 4111527
Price to Book Ratio 0.00
Return on Assets (%) -1.63
Return on Capital (%) -1.84
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 88.24
Total Assets 654.08
Total Liabilities 654.08
Total Equity 551.20
Share Outstanding 3850200
Price to Book Ratio 0.00
Return on Assets (%) -6.24
Return on Capital (%) -7.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 66.66
Total Assets 532.70
Total Liabilities 532.70
Total Equity 486.43
Share Outstanding 100200
Price to Book Ratio 0.00
Return on Assets (%) -3.40
Return on Capital (%) -3.73
Particulars MAR 2024 (Values in Cr)
Net Income 35.55
Cash from Operations -23.55
Cash from Investing -705.12
Cash from Financing 862.94
Net change in Cash 121.20
Free Cash Flow -18.13
Particulars MAR 2023 (Values in Cr)
Net Income -3.68
Cash from Operations -32.88
Cash from Investing -48.59
Cash from Financing 72.76
Net change in Cash -21.14
Free Cash Flow -27.36
Particulars MAR 2022 (Values in Cr)
Net Income -19.81
Cash from Operations -24.36
Cash from Investing -161.73
Cash from Financing 211.19
Net change in Cash 14.19
Free Cash Flow -14.49
Particulars MAR 2021 (Values in Cr)
Net Income -10.83
Cash from Operations -64.10
Cash from Investing -30.86
Cash from Financing 88.71
Net change in Cash -10.84
Free Cash Flow -54.57
Particulars MAR 2024 (Values in Cr)
Net Income 24.36
Cash from Operations -73.85
Cash from Investing -762.69
Cash from Financing 925.56
Net change in Cash 87.22
Free Cash Flow -72.81
Particulars MAR 2023 (Values in Cr)
Net Income -12.45
Cash from Operations -54.37
Cash from Investing -58.29
Cash from Financing 91.11
Net change in Cash -24.08
Free Cash Flow -53.85
Particulars MAR 2022 (Values in Cr)
Net Income -40.84
Cash from Operations -43.73
Cash from Investing -68.79
Cash from Financing 127.47
Net change in Cash 13.98
Free Cash Flow -41.15
Particulars MAR 2021 (Values in Cr)
Net Income -18.15
Cash from Operations -68.64
Cash from Investing -7.20
Cash from Financing 75.49
Net change in Cash 0.09
Free Cash Flow -62.09
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 6794.75 177.13 51.61 241544.84 2678.00 / 8345.85
WARREN TEA LTD. 61.24 0.00 0.77 73.18 35.66 / 86.00
MULLER & PHIPPS (INDIA) LTD. 547.55 0.00 -22.96 34.22 172.60 / 726.20
FUTURE ENTERPRISES LTD 0.75 0.00 -0.12 54.83 0.68 / 0.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 6794.75 178.95 47.38 241544.84 2678.00 / 8345.85
Saptak Chem And Business Limit 3.20 0.00 -1.57 3.43 2.40 / 5.37
WARREN TEA LTD. 61.24 0.00 0.84 73.18 35.66 / 86.00
MULLER & PHIPPS (INDIA) LTD. 547.55 0.00 -22.97 34.22 172.60 / 726.20

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 1334.70
  • 26 Days 1367.30
  • 10 Days 1338.90
  • 50 Days 1372.40
  • 12 Days 1357.00
  • 100 Days 1318.60
  • 20 Days 1360.90
  • 200 Days 1158.30
1349.17
PIVOT
First Resistance 1378.63
Second Resistance 1404.47
Third Resistance 1433.93
First Support 1323.33
Second Support 1293.87
Third Support 1268.03
RSI 47.97
MACD -10.24
Commodity Channel Index (CCI) -48.72
ADX 20.75
Williams % R -70.86

Over 1 Month

down

-0.19

Over 3 Months

down

0.14

Over 6 Months

down

31.78

Over 1 Year

down

17.68

Over 3 Years

down

0.00

Over 5 Years

down

0.00

ENTERO HEALTHCARE SOLU L Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

ENTERO HEALTHCARE SOLU L Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
16.0
Promoter Holdings
52.43
FII
23.82
DII
7.72
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Orbimed Asia Iii Mauritius Limited Shareholding of Promoter and Promoter Group 1.6538929E7 38.03
Prabhat Agrawal Shareholding of Promoter and Promoter Group 4028395.0 9.26
Government Of Singapore Public Shareholding 2705713.0 6.22
Prem Sethi Shareholding of Promoter and Promoter Group 2239842.0 5.15
Invesco India Aggressive Hybrid Fund Public Shareholding 2059500.0 4.74
Smallcap World Fund, Inc Public Shareholding 1998543.0 4.6
Clsa Global Markets Pte. Ltd-odi Public Shareholding 1093840.0 2.51
Stichting Depositary Apg Emerging Markets Equity Pool Public Shareholding 927203.0 2.13
Arti Mittal Shareholding of Promoter and Promoter Group 100.0 0.0
Richa Agarwal Shareholding of Promoter and Promoter Group 300.0 0.0

ENTERO HEALTHCARE SOLU L

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About ENTERO HEALTHCARE SOLU L

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by ENTERO HEALTHCARE SOLU L

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Entero Healthcare Solutions Ltd?

Answer Field

The share price of Entero Healthcare Solutions Ltd for NSE is ₹ 1349.8 and for BSE is ₹ 1349.9.

What is the Market Cap of Entero Healthcare Solutions Ltd?

Answer Field

The market cap of Entero Healthcare Solutions Ltd for NSE is ₹ 58,70.78 Cr. and for BSE is ₹ 58,71.22 Cr. as of now.

What is the 52 Week High and Low of Entero Healthcare Solutions Ltd?

Answer Field

The 52 Week High and Low of Entero Healthcare Solutions Ltd for NSE is ₹ 1584.25 and ₹ 970.00 and for BSE is ₹ 1583.00 and ₹ 974.45.

How to Buy Entero Healthcare Solutions Ltd share?

Answer Field

You can trade in Entero Healthcare Solutions Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Entero Healthcare Solutions Ltd?

Answer Field

The 1 year returns on the stock has been 17.68%.

What is the Current Share Price of Entero Healthcare Solutions Ltd?

Answer Field

Entero Healthcare Solutions Ltd share price is for NSE ₹ 1349.8 & for BSE ₹ 1349.9 as on Dec 02 2024 03:29 PM.

What is the Market Cap of Entero Healthcare Solutions Ltd Share?

Answer Field

The market cap of Entero Healthcare Solutions Ltd for NSE ₹ 58,70.78 & for BSE ₹ 58,71.22 as on Dec 02 2024 03:29 PM.

What is the P/E Ratio of Entero Healthcare Solutions Ltd Share?

Answer Field

As on Dec 02 2024 03:29 PM the price-to-earnings (PE) ratio for Entero Healthcare Solutions Ltd share is 79.09.

What is the PB ratio of Entero Healthcare Solutions Ltd Share?

Answer Field

As on Dec 02 2024 03:29 PM, the price-to-book (PB) ratio for Entero Healthcare Solutions Ltd share is 382.51.

How to Buy Entero Healthcare Solutions Ltd Share?

Answer Field

You can trade in Entero Healthcare Solutions Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Entero Healthcare Solutions Ltd Share on Bajaj Broking App?

Answer Field

To buy Entero Healthcare Solutions Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Entero Healthcare Solutions Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text
loader